Managing Respiratory Failure in Myositis with Lung Volume Recruitment Therapy
Author Information
Author(s): Takahashi Seiya MD, PhD, Inoue Hiroyasu RPT, PhD, Amano Shizuki MD, Shinohara Takahiro MD, Mori Sara MD, Onizawa Kaho MD, Nabeshima Yoko MD, Komuro Hiroyasu MD, Yasumoto Taro MD, PhD, Mitsuhashi Rihito BS, Watanabe Daishi MD, PhD, Komaba Kazuki OTR, MS, Futamura Akinori MD, PhD, Nogawa Satoshi MS, Kinno Ryuta MD, PhD
Primary Institution: Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan
Hypothesis
Can modified lung volume recruitment therapy effectively treat immunotherapy-resistant respiratory failure in patients with anti-mitochondrial M2 antibody-positive myositis?
Conclusion
The modified lung volume recruitment therapy significantly improved respiratory function in a patient with severe immunotherapy-resistant respiratory failure.
Supporting Evidence
- The patient was weaned off ventilation 48 days after starting modified lung volume recruitment therapy.
- Both objective and subjective measures of respiratory function showed significant improvements.
- The therapy allowed for adjustments based on the patient's symptoms, enhancing safety and effectiveness.
Takeaway
A man with severe breathing problems due to a muscle disease got better after a special breathing therapy that helped him breathe on his own again.
Methodology
The patient underwent modified lung volume recruitment therapy using the LIC TRAINER device to improve respiratory function.
Limitations
This report is based on a single case study without a control group, limiting the generalizability of the findings.
Participant Demographics
A 60-year-old man with anti-mitochondrial M2 antibody-positive myositis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website